SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn-Reference-Cited by-同舟云学术

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn

Published:2021-05 Issue:5 Volume:174 Page:687-690
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Connors Mark¹^ORCID,Graham Barney S.²^ORCID,Lane H. Clifford¹^ORCID,Fauci Anthony S.¹

Affiliation:

1. the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (M.C., H.C.L., A.S.F.)

2. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (B.S.G.).

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Vaccine Research Center

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 aşısına bağlı yan etkiler; faydalar risklerden ağır basıyor mu?;Journal of Biotechnology and Strategic Health Research;2023-12-31

2. A Critical Assessment of COVID-19 Genomic Vaccines;Current Topics in Medicinal Chemistry;2023-10

3. Spondias mombin: biosafety and GC–MS analysis of anti-viral compounds from crude leaf extracts;Advances in Traditional Medicine;2023-09-07

4. The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model;Frontiers in Immunology;2023-08-16

5. The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection;Nutrients;2023-08-03